RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 43.97
+3.12 (7.64%)
Apr 1, 2025, 2:45 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 20.05 billion as of April 1, 2025. Its market cap has decreased by -3.41% in one year.
Market Cap
20.05B
Enterprise Value
21.65B
Revenue
1.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
43.97
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 28.53B to 20.05B, a decrease of -29.72%. That is a compound annual growth rate of -7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 20.05B | 52.34% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 309.09B |
| Shenzhen Mindray Bio-Medical Electronics | 287.93B |
| WuXi AppTec | 194.66B |
| Aier Eye Hospital Group | 125.42B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.96B |
| Yunnan Baiyao Group Co.,Ltd | 100.54B |
| Shanghai United Imaging Healthcare | 100.16B |
| Sichuan Biokin Pharmaceutical | 95.03B |